Correlation of longtime efficacy maintenance PARP inhibitor therapy with pre-treatment in a single-institution experience.

M. Nicoletto,Andrea Grego,A. Baldoni,G. Tasca,A. Sommariva,M. Tonello,V. Torri,P. Pilati

Published 2020 in Journal of Clinical Oncology

ABSTRACT

e18084Background: The use of PARP inhibitors (Olaparib-Niraparib) has shown an important benefit in PFS in patients with relapsed ovarian cancer both with gBRCA and non-BRCA mutation. Methods: This...

PUBLICATION RECORD

Publication year
2020
Venue
Journal of Clinical Oncology
Publication date
2020-05-25
Fields of study
Medicine
Identifiers
DOI 10.1200/jco.2020.38.15_suppl.e18084
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

No citing papers are available for this paper.